Andreassen BK - Search Results

1

Cohort Profile: Norwegian Offshore Petroleum Workers (NOPW) Cohort.

Stenehjem JS, Babigumira R, Hosgood HD, Veierød MB, Samuelsen SO, Bråtveit M, Kirkeleit J, Rothman N, Lan Q, Silverman DT, Friesen MC, Robsahm TE, Kjærheim K, Andreassen BK, Shala NK, Liu FC, Strand LÅ, Grimsrud TK. Stenehjem JS, et al. Among authors: andreassen bk. Int J Epidemiol. 2021 May 17;50(2):398-399. doi: 10.1093/ije/dyaa107. Int J Epidemiol. 2021. PMID: 32879941 Free PMC article. No abstract available.

2

[Cancer--not just bad luck!].

Andreassen BK, Vos L, Grimsrud TK. Andreassen BK, et al. Tidsskr Nor Laegeforen. 2015 Mar 10;135(5):416-7. doi: 10.4045/tidsskr.15.0040. eCollection 2015 Mar 10. Tidsskr Nor Laegeforen. 2015. PMID: 25761022 Free article. Norwegian. No abstract available.

3

Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE. Gislefoss RE, et al. Among authors: andreassen bk. BMJ Open. 2018 Mar 30;8(3):e019309. doi: 10.1136/bmjopen-2017-019309. BMJ Open. 2018. PMID: 29602840 Free PMC article.

4

Bladder cancer survival: Women better off in the long run.

Andreassen BK, Grimsrud TK, Haug ES. Andreassen BK, et al. Eur J Cancer. 2018 May;95:52-58. doi: 10.1016/j.ejca.2018.03.001. Epub 2018 Apr 7. Eur J Cancer. 2018. PMID: 29635144 Free article.

5

Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.

Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE. Berge LAM, et al. Among authors: andreassen bk. BMJ Open. 2019 Feb 20;9(2):e025246. doi: 10.1136/bmjopen-2018-025246. BMJ Open. 2019. PMID: 30787091 Free PMC article.

6

Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE. Berge LAM, et al. Among authors: andreassen bk. Clin Epidemiol. 2020 Feb 21;12:193-202. doi: 10.2147/CLEP.S241249. eCollection 2020. Clin Epidemiol. 2020. PMID: 32110111 Free PMC article.

7

Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE. Hektoen HH, et al. Among authors: andreassen bk. Cancer Med. 2020 Jun;9(12):4420-4432. doi: 10.1002/cam4.3060. Epub 2020 Apr 21. Cancer Med. 2020. PMID: 32319230 Free PMC article.

8

T1 bladder cancer in Norway: treatment and survival.

Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK. Blindheim A, et al. Among authors: andreassen bk. Scand J Urol. 2020 Oct;54(5):370-375. doi: 10.1080/21681805.2020.1803401. Epub 2020 Aug 12. Scand J Urol. 2020. PMID: 32783590

9

Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE. Berge LAM, et al. Among authors: andreassen bk. Clin Epidemiol. 2020 Dec 18;12:1389-1401. doi: 10.2147/CLEP.S269446. eCollection 2020. Clin Epidemiol. 2020. PMID: 33376408 Free PMC article.

10

The use of reTURB in T1 bladder cancer: a Norwegian population-based study.

Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK. Blindheim AJ, et al. Among authors: andreassen bk. Scand J Urol. 2021 Aug;55(4):268-274. doi: 10.1080/21681805.2021.1917652. Epub 2021 May 17. Scand J Urol. 2021. PMID: 33998957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page